Mida Pezeshkian, PhD brings deep operational expertise in scaling life sciences and digital health companies, with a proven track record of value creation across venture and PE-backed portfolio companies. Her unique combination of scientific expertise and commercial acumen has consistently delivered successful exits through strategic product development and rapid commercialization.
As a hands-on operator, she has demonstrated success in:
Building and scaling product organizations from inception to exit
Developing secure HIPAA-compliant digital health products
Creating and executing data-driven go-to-market strategies in highly regulated markets
Leading cross-functional teams across engineering, product, marketing, and data science
Her technical credentials include a PhD in Biological and Biomedical Sciences from Oakland University, where she developed and patented novel biosensor technology for cancer diagnostics. She completed postdoctoral training at the University of Michigan Medical School and is pursuing a global executive MBA at INSEAD.
Her expertise in digital health transformation is particularly valuable as life sciences companies accelerate their digital strategies to gain competitive advantages in patient access and experience. She currently serves as a board member and advisor to multiple organizations, leveraging her experience in developing strategic roadmaps for scalable growth in regulated markets.
Visit The Lab to learn more about Mida’s philosophy and frameworks.
Founder & Principal
Mida Pezeshkian, PhD
Senior Advisor, AI & Machine Intelligence
Chandler T Wilson
Chandler T Wilson is a pioneer in machine intelligence, alternative data, and OSINT (Open Source Intelligence). Chandler brings over 15 years of global experience working with world-renowned organizations. He has led the development of groundbreaking integrated and strategic capabilities at blue-chip companies and institutions, including the European Commission, European Parliament, Walmart, Wells Fargo, and HSBC.
Drawing upon his extensive background in building first-of-their-kind AI and machine intelligence programs, Chandler provides bridge_ci's clients with a unique combination of technical expertise and proven business acumen. His approach incorporates cutting-edge techniques and frameworks that seamlessly integrate business strategy and machine learning—concepts he has refined and applied for more than a decade, ensuring clients receive innovative solutions tailored to their specific needs and goals.
Academically, he is currently advancing cutting-edge research for his DPhil (PhD) at the University of Oxford, exploring how complex information systems influence outcomes across M&A, financial markets, politics, and business using machine learning and applied mathematics. He also holds an MBA from Northwestern University’s Kellogg School of Management and a Master’s in Political Strategy and Communications from the University of Kent, where he conducted the first research that used advanced natural language processing, topological data analysis, graph theory, open-source intelligence, financial data, and AI to quantify political trends and communication strategies within the European Union.
“STEMA_cg took an immersive approach to our digital presence needs. The first steps included meetings with the department leads, and staff to better understand what they do, how it contributes to the organization, and how these teams build collective value for our customers. From there the architecture of the site was crafted to make certain the internal narrative could easily translate to visitors. Ultimately, we couldn't be more pleased with the structure and messaging.”
Steve Riedmuller, CCO Neochromosome
“I had the opportunity to work with Mida at a start up in the next generation sequencing market where she was a talented product manager and after selling this company, I hired her as a consultant at another company to do a strategic review for product development into the clinical testing and research market.”
Nathan Wood, CEO